EMA/PE/0000232776
Submitted by Anonymous (not verified) on 3 July 2026 - 8:50
EMA/PE/0000232776
EMA/PE/0000232776
Clinical Trials Information System (CTIS): Information day, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 17 June 2026, 12:30 (CEST) to 17 June 2026, 17:30 (CEST)
EMA/PE/0000228536
Tegsedi
Medicine shortage communication (MSC): TEGSEDI® (inotersen sodium, 284 mg solution for injection in prefilled syringe): planned marketing cessation (discontinuation)
EMA/PE/0000238070
Opinion/decision on a Paediatric investigation plan (PIP): Rezzayo, rezafungin acetate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP number: P/0343/2024
EMA/PE/0000236239
EMA/PE/0000232757
EMA/PE/0000182928